Cargando…

The Brazilian experience of implementing the active pharmacovigilance of dolutegravir

In 2017, the Ministry of Health Brazilian started using dolutegravir (DTG) 50 mg to all people living with HIV who began antiretroviral therapy (ART) or rescue regimens. Although DTG is thought to have better tolerability levels and a lower possibility of causing adverse reactions, it is necessary t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batista, Cynthia Julia Braga, Correa, Renato Girade, Evangelista, Livia Ramalho, Fleck, Karen, Silva, Leandro, Renaud, Francoise, Vitoria, Marco, Doherty, Meg, Benzaken, Adele Schwartz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417631/ https://www.ncbi.nlm.nih.gov/pubmed/30855509 http://dx.doi.org/10.1097/MD.0000000000014828

Ejemplares similares

The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy
por: Mesquita, Fabio, et al.
Publicado: (2016)

HIV and syphilis in the context of community vulnerability among indigenous people in the Brazilian Amazon
por: Benzaken, Adele Schwartz, et al.
Publicado: (2017)

Presenting national HIV/AIDS and sexually transmitted disease research in Brazil
por: Benzaken, Adele Schwartz, et al.
Publicado: (2018)

Brazilian Protocol for Sexually Transmitted Infections 2020: acquired syphilis
por: Freitas, Francisca Lidiane Sampaio, et al.
Publicado: (2021)

Point-of-care screening for syphilis and HIV in the borderlands: challenges in implementation in the Brazilian Amazon
por: Ruffinen, Carole Zen, et al.
Publicado: (2015)

Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects
por: Mofenson, Lynne M, et al.
Publicado: (2019)

Pharmacovigilance in Italy: An overview
por: Mazzitello, Carmela, et al.
Publicado: (2013)

Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis
por: Kanters, Steve, et al.
Publicado: (2020)

Dolutegravir: Virologic response and tolerability of initial antiretroviral regimens for adults living with HIV
por: Correa, Analú, et al.
Publicado: (2020)

Self-reported syphilis and associated factors among Brazilian young adults: findings from a nationwide survey
por: Kops, Natália Luiza, et al.
Publicado: (2019)

Etiology of Genital Ulcer Disease in a Sexually Transmitted Infection Reference Center in Manaus, Brazilian Amazon
por: Gomes Naveca, Felipe, et al.
Publicado: (2013)

Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach
por: Benzaken, Adele Schwartz, et al.
Publicado: (2019)

Providing antiretroviral therapy to all who are HIV positive: the clinical, public health and programmatic benefits of Treat All
por: Ford, Nathan, et al.
Publicado: (2018)

WHO guidance to support HIV care models during the Covid-19 era
por: Ford, Nathan, et al.
Publicado: (2021)

PrEP adopted by the brazilian national health system: What is the size of the demand?
por: Luz, Paula M., et al.
Publicado: (2018)

The promise of paediatric dolutegravir
por: Golin, Rachel, et al.
Publicado: (2021)

Effectiveness and safety of dolutegravir and raltegravir for treating children and adolescents living with HIV: a systematic review
por: Townsend, Claire L., et al.
Publicado: (2022)

HIV prevalence and sexual behavior among young male conscripts in the Brazilian army, 2016
por: Sperhacke, Rosa Dea, et al.
Publicado: (2018)

Probing Resistance Mutations in Retroviral Integrases by Direct Measurement of Dolutegravir Fluorescence
por: Thierry, Eloïse, et al.
Publicado: (2017)

Pharmacovigilance
por: Griffin, J. P.
Publicado: (1992)

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
por: Baldo, Paolo, et al.
Publicado: (2018)

Getting to zero HIV deaths: progress, challenges and ways forward
por: Ford, Nathan, et al.
Publicado: (2013)

Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017)

Open Science, equity and the Brazilian context
por: Reis-Santos, Barbara, et al.
Publicado: (2022)

Annotation and detection of drug effects in text for pharmacovigilance
por: Thompson, Paul, et al.
Publicado: (2018)

Sociodemographic determinants of attrition in the HIV continuum of care in Brazil, in 2016
por: Pascom, Ana Roberta Pati, et al.
Publicado: (2018)

Hepatitis B and C prevalence and risk factors among young men presenting to the Brazilian Army: A STROBE-compliant national survey-based cross-sectional observational study
por: da Motta, Leonardo Rapone, et al.
Publicado: (2019)

Dictionary of pharmacovigilance /
por: Alghabban, Amer
Publicado: (2004)

Pharmacovigilance in vaccines
por: Budhiraja, Salil, et al.
Publicado: (2010)

Pharmacovigilance and Pharmacoepidemiology
Publicado: (2008)

Challenges in pharmacovigilance
por: Dikshit, R. K.
Publicado: (2010)

Pharmacovigilance on olanzapine
por: Lingeswaran, Anand, et al.
Publicado: (2010)

Pharmacovigilance inspections
por: Fitzgerald, Patricia
Publicado: (2008)

Pharmacovigilance in Asia
por: Biswas, Pipasha
Publicado: (2013)

Pharmacovigilance in radiopharmaceuticals
por: Kumar, Rishi, et al.
Publicado: (2016)

Pharmacovigilance in oncology
por: Baldo, Paolo, et al.
Publicado: (2018)

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? A case report
por: Mulindwa, Frank, et al.
Publicado: (2023)

Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
por: Chapola, John C., et al.
Publicado: (2023)

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report
por: Mulindwa, Frank, et al.
Publicado: (2023)

Potential safety signals for antibacterial agents from the Brazilian national pharmacovigilance database (Vigimed/VigiFlow)
por: Barbosa, Luiza Hoehl Loureiro Alves, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fd4qu1dv5hsfr46bm8icd162rh